36.6 F
New York
Wednesday, January 27, 2021

eBay Inc. [NASDAQ: EBAY] In Talks To Sell Classified Ads Unit To Adevinta

Must read

JPMorgan [NYSE: JPM] Announced To Initiate A Digital Retail Bank In The United Kingdom

JPMorgan Chase revealed that the company will launch a new digital retail bank in the United Kingdom offering the customer of the region...

Humanigen [NASDAQ: HGEN] Announces Expansion Of Manufacturing Agreement With Ajinomoto Bio-Pharma

Humanigen Inc revealed that the company has extended the manufacturing agreement with  Ajinomoto BioPharma to support the fill-finish of Lenzilumab. The Lenzilumab is...

Synchrony [NYSE: SYF] Announced To Purchase Allegro Credit

Synchrony Financials revealed that the company entered into a definitive contract to Purchase Allegro Credit. Allegro Credit's customer base and merchant network will...

Vericel Corp [NASDAQ: VCEL] Names Joe Mara As The New CFO

Vericel Corporation revealed that the company has named Joe Mara as the CFO of the company. He has over more than 20 years...

eBay Inc. [NASDAQ: EBAY] is in discussion with Adevinta to sell its classified Ads business as it is turning its focus towards its core marketplace business. The price is not disclosed yet but it is believed that eBay is planning to sell for roughly $8 billion or more but the official announcement will be disclosed soon.

As the coronavirus continued to spread across the world people are turning towards online modes of shopping and for various other purposes. Shares of Adevinta halted after the announcement of the deal between eBay and Norwegian group Adevinta.

On the other hand, Shares of eBay had tumbled down 0.89% during the trading of Friday. It has a closing price of $58.13. eBay had a trading volume of 6.63 million as compared to the average volume of 12.31 million.

In the past 52-weeks of trading, this company’s stock has fluctuated between the low of $26.02 and a high of $61.06. If we turn our focus on liquidity, it has a current ratio and a quick ratio of 1.30, and a debt-to-equity ratio of 4.13.

Continuing to look at its profitability, it has return on assets of 24.30%, return on equity of 151.40% and return on investment of 17.40%. This company has a Gross Margin of 76.90%, an operating margin of 22.20%, and a profit margin of 44.40%.

More articles

Latest article

A Paychex [NASDAQ: PAYX] Subsidiary Announces Strategic Collaboration With Zoho Books

SurePayroll, a subsidiary of Paychex company revealed that the company has formed a collaboration with Zoho books. SurePAyroll is a provider of small...

MGP Ingredients [NASDAQ: MGPI] Announced To Acquire Luxco and Its Affiliate Companies

MGP Ingredients  revealed a definitive contract to purchase Luxco, Inc and its affiliated companies. Luxco is an alcohol beverage company with more than 60...

Conformis [NASDAQ: CFMS] Entered A Non-Exclusive agreement with SITES Medical

Conformis Inc revealed that the company inked a development and supply contract with sites medical. Both of the companies will work together to...

Colliers International [NASDAQ: CIGI] Announces Executive Leadership Changes For Australian Business

Colliers International  reported that the company has named Malcom Tyson as the new Chief Executive Officer. He is appointed as the CEO so...

Korn Ferry [NYSE: KFY] Announces Expansion Of Its Footprint In Russian Market

Korn Fery revealed that the company is expanding its footprint in Russia. Moreover, it is adding a high expertise team of executive search...

Haemonetics [NYSE: HAE] To Purchase Cardiva For An Upfront Payment Of $475M

Haemonetics Corporation revealed that the company has inked a definitive contract to purchase Cardiva Medical Inc. Under the contract, Haemontics will pay an...

Philips [NYSE: PHG] To Purchase Capsule Technologies For Cash Consideration Of USD 635M

Koninklijke Philip revealed that the company has inked a contract to purchase Capsule technologies. The company will pay a cash price of $636...

Thermo Fisher Scientific [NYSE: TMO] To Purchase Mesa Biotech For Approx. $450M In Cash

Thermo fisher scientific inc revealed that the company has signed a definitive contract to purchase Mesa Biotech. Thermo will pay a value price...